Scalper1 News
With earnings season winding down, only a handful of leading stocks have yet to report results, but Valeant Pharmaceuticals (VRX) and Jazz Pharmaceuticals (JAZZ) could give investors a late-season lift. Jazz, Valeant and Amira Nature Foods (ANFI) are the IBD 50 stocks set to provide quarterly results this week. Jazz is No. 4 on the IBD 50 and is on tap to report financials Tuesday. It’s grown in part by buying other drugmakers. Wall Street liked Scalper1 News
Scalper1 News